Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Leukemia survival rates prior and after introduction of Imatinib

This statistic shows the leukemia patients survival rates before and after introduction of drug Imatinib, over a period of five years. The survival rate has increased drastically from 31 percent up to 89 percent.

Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2015

Region

Worldwide

Survey time period

2006 to 2014

Supplementary notes

* This statistic was assembled by PhRMA from various sources publsihed between 2006 and 2014.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Medical biotech industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.